Iris Pharmachem (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 04-07-2024
- Paid Up Capital ₹ 0.48 M
as on 04-07-2024
- Company Age 24 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.90 Cr
as on 04-07-2024
- Satisfied Charges ₹ 1.05 Cr
as on 04-07-2024
- Revenue 5.62%
(FY 2023)
- Profit -116.37%
(FY 2023)
- Ebitda -1.49%
(FY 2023)
- Net Worth -0.92%
(FY 2023)
- Total Assets 27.71%
(FY 2023)
About Iris Pharmachem (India)
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.48 M.
The company currently has active open charges totaling ₹2.90 Cr. The company has closed loans amounting to ₹1.05 Cr, as per Ministry of Corporate Affairs (MCA) records.
Kiritkumar Bhatt and Shamik Bhatt serve as directors at the Company.
- CIN/LLPIN
U24230GJ2000PTC037756
- Company No.
037756
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Apr 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Iris Pharmachem (India) Private Limited offer?
Iris Pharmachem (India) Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Nutritional Supplements.
Who are the key members and board of directors at Iris Pharmachem (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kiritkumar Bhatt  | Managing Director | 11-Apr-2000 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shamik Bhatt | Director | 11-Apr-2000 | Current |
Financial Performance of Iris Pharmachem (India).
Iris Pharmachem (India) Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.62% increase. The company also saw a substantial fall in profitability, with a 116.37% decrease in profit. The company's net worth dipped by a decrease of 0.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Iris Pharmachem (India)?
In 2023, Iris Pharmachem (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Citro Calcoat Private LimitedActive 22 years 2 monthsKiritkumar Bhatt and Shamik Bhatt are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 27 Jun 2015 | ₹2.90 Cr | Open |
Kotak Mahindra Bank Limited Creation Date: 01 Mar 2016 | ₹1.05 Cr | Satisfied |
How Many Employees Work at Iris Pharmachem (India)?
Iris Pharmachem (India) has a workforce of 4 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Iris Pharmachem (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iris Pharmachem (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
